Skip to main navigation Skip to search Skip to main content

Glucosidase-beta variations and Lewy body disorders

  • Matthew J. Farrer
  • , Lindsey N. Williams
  • , Avi A. Algom
  • , Jennifer Kachergus
  • , Mary M. Hulihan
  • , Owen A. Ross
  • , Alex Rajput
  • , Spiridon Papapetropoulos
  • , Deborah C. Mash
  • , Dennis W. Dickson

Research output: Contribution to journal › Article › peer-review

Abstract

It has been proposed that there is an increased frequency of glucosidase-β mutations in Lewy body disorders. Our comprehensive DNA sequencing approach found a small number of glucosidase-β mutations in 101 neuropathologically defined Lewy body disease cases (3%) compared to 99 healthy post-mortem controls (1%); odds ratio 3.0 (95% CI: 0.3-29, p = 0.3). All three affected carriers were classified as diffuse Lewy body disease (n = 3/50; 6%). Our study suggests glucosidase-β variants have a limited role in susceptibility to Lewy body disease in North America.

Original languageEnglish
Pages (from-to)414-416
Number of pages3
JournalParkinsonism and Related Disorders
Volume15
Issue number6
DOIs
StatePublished - Jul 2009
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Keywords

  • Gaucher
  • Genetic
  • Lewy body
  • Parkinson

Fingerprint

Dive into the research topics of 'Glucosidase-beta variations and Lewy body disorders'. Together they form a unique fingerprint.

Cite this